Jennifer C. Price, M.D.
- Associate Clinical Professor of Medicine Hepatology and Liver Transplantation Department of Medicine
Contact Information
Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 502-1429 - Phone
(415) 476-0659 - Fax
[email protected]
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 502-1429 - Phone
(415) 476-0659 - Fax
[email protected]
Education
Stanford University, B.A., Human Biology, 1999
Johns Hopkins University School of Medicine, M.D., 2004
Johns Hopkins University Bloomberg School of Public Health, Ph.D. candidate, Graduate Training Program in Clinical Investigation, 2008-present
Fellowships
- Johns Hopkins Hospital, Fellow, Gastroenterology and Hepatology, 2007-2011
- Johns Hopkins Hospital, Fellow, Transplant Hepatology, 2011-2012
Clinical Expertise
- Alcoholic Liver Disease
- Autoimmune Hepatitis
- Cirrhosis
- Drug-Induced Hepatitis
- Fulminant Hepatic Failure
- Hemochromatosis
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma (Liver Cancer)
- Liver Transplantation
- Living Donor Liver Transplantation
- Nonalcoholic Fatty Liver Disease
- Polycystic Liver Disease
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
Biography
Dr. Jennifer Cohen Price is an Assistant Clinical Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include liver disease in HIV infection, the natural history and treatment of viral hepatitis, and nonalcoholic fatty liver disease.
Dr. Price received her medical degree at Johns Hopkins University School of Medicine in 2004. She continued her medical training at Johns Hopkins, where she completed her residency, gastroenterology and hepatology fellowship, and transplant hepatology fellowship. She is a fellow of the American College of Physicians, and a member of the American College of Gastroenterology, American Gastroenterological Association, and American Association for the Study of Liver Diseases. Dr. Price is certified by the American Board of Internal Medicine in internal medicine and gastroenterology.
Awards & Honors
Award
Confired By
Date
Research & Funding
Data provided by UCSF Profiles, powered by CTSI
- San Francisco Bay Clinical Trials Unit (CTU)Sponsor: NIHSponsor ID: UM1AI069496Funding Period:Mar 2007-Nov 2027Co-Investigator
- SF Bay Area MACS/WIHS Combined Cohort StudySponsor: NIH/NHLBISponsor ID: U01HL146242Funding Period:Apr 2019-Mar 2026Co-Principal Investigator
- Ancillary Studies of NAFLD and NASH in HIV infected AdultsSponsor: NIH/NIDDKSponsor ID: R01DK121378Funding Period:Mar 2020-Jan 2025Co-Investigator
Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
- Study ID: NCT05551273Start Date: Nov 2022Estimated Completion Date: Nov 2024Condition(s): Hepatitis B, HIV/AIDS
- Study ID: NCT05023044Start Date: May 2022Estimated Completion Date: Jan 2025Condition(s): Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Steatohepatitis, HIV/AIDS, Liver Disease
- Study ID: NCT04677153Start Date: Aug 2021Estimated Completion Date: Aug 2023Condition(s): Hepatitis C
- Study ID: NCT04795219Start Date: May 2021Estimated Completion Date: Jun 2024Condition(s): Nonalcoholic Fatty Liver Disease, HIV/AIDS
- Study ID: NCT03734393Start Date: Jan 2019Estimated Completion Date: Jun 2024Condition(s): HIV/AIDS, Liver Transplant
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 82
Data provided by UCSF Profiles, powered by CTSI
- Bhattacharya D, Aronsohn A, Price J, Lo Re V, AASLD-IDSA HCV Guidance Panel . Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023 May 25. View in PubMed
- Duarte MJ, Tien PC, Somsouk M, Price JC. The human microbiome and gut-liver axis in people living with HIV. Curr HIV/AIDS Rep. 2023 06; 20(3):170-180. View in PubMed
- Marks KM, Kang M, Umbleja T, Avihingsanon A, Sugandhavesa P, Cox AL, Vigil K, Perazzo H, Price JC, Katsidzira L, Vernon C, Alston-Smith B, Sherman KE, ACTG 5379 Study Team . Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV. Clin Infect Dis. 2023 Apr 05. View in PubMed
- Argirion I, Mahale P, Pfeiffer RM, Liu P, Adimora AA, Akiyama MJ, Bolivar HH, French A, Plankey M, Price JC, Rana A, Sheth A, Koshiol J, Seaberg EC, Kuniholm MH, Glenn J, O'Brien TR. Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States. Front Med (Lausanne). 2023; 10:1070420. View in PubMed
- Michael A Yu, Logan Gerig, Cyra Christina Mehta, Oyindamola Yusef, Joffi Musonge-Effoe, Jessica Alvarez, Amanda B Spence, Svenja Albrecht, Maria L L Alcaide, Adaora A Adimora, Alison G Abraham, Audrey L French, Michael Augenbraun, Kathryn Anastos, Jennifer C Price, Phyllis C Tien, Cecile D Lahiri. 1276. Noninvasive Assessment of Change in Hepatic Fibrosis Following Initiation of Integrase Inhibitors in Women Living with HIV. Open Forum Infectious Diseases. 2022 Dec 15; 9(Supplement_2). View in PubMed
- View All Publications
In the News
- UCSF General Surgery Residency Program - - October 16, 2020Hillary Braun, M.D., a general surgery research resident, was named the 2020 Bruce A. Luxon Emerging Liver Scholar by the American Association for the Study of Liver Diseases (AASLD). The Emerging Liver Scholars program selects 20 medicine or surgery residents who are interested in the study of liver diseases to participate in a curated program at the AASLD's annual Liver Meeting, which will be held virtually this year November 13-16, 2020. In addition to participation in the Emerging Liver [...]
